文献速递儿科与产科急症重症综合管理与镇静镇痛

Covid-19对严重孕产妇疾病风险的影响

Impact of Covid-19 on risk of severe maternal morbidity.
PubMed 文献 · Crit Care · 2023-09-05
一句话结论基于魁北克162,576例妊娠的人群研究显示,妊娠期Covid-19感染使严重孕产妇疾病风险约翻倍(RR 2.02,95%CI 1.76-2.31)。

该研究在加拿大魁北克开展基于人群的队列分析,纳入2020年3月至2022年3月间162,576例妊娠,评估Covid-19感染与妊娠至产后42天内严重孕产妇疾病的关联。采用校正对数二项回归模型估计风险比(RR)及95%CI。结果显示,Covid-19感染使严重孕产妇疾病风险约翻倍(RR 2.02,95%CI 1.76-2.31),急性肾衰竭(RR 3.01)、严重出血(RR 1.49)风险升高;重度产前感染(RR 13.60)和围产期感染(RR 20.93)风险最高,轻度产前感染亦升高风险(RR 3.43)。结论提示妊娠期Covid-19感染增加肾、栓塞及出血等危及生命的并发症风险。

要点

  • 妊娠期Covid-19感染与严重孕产妇疾病风险约翻倍相关(RR 2.02,95%CI 1.76-2.31)。
  • 重度产前感染(RR 13.60,95%CI 10.72-17.26)和围产期感染(RR 20.93,95%CI 17.11-25.60)与严重孕产妇疾病强烈相关。
  • 轻度产前感染亦升高严重孕产妇疾病风险(RR 3.43,95%CI 2.42-4.86)。
  • 急性肾衰竭风险升高(RR 3.01,95%CI 1.79-5.06),严重出血风险升高(RR 1.49,95%CI 1.09-2.04)。
  • 野生型、alpha和delta变异株流行期间严重孕产妇疾病风险约升高3倍,omicron期间约1.2倍。

适用人群与场景

  • 2020年3月至2022年3月加拿大魁北克162,576例妊娠,评估妊娠至产后42天内的严重孕产妇疾病。

研究设计与关键结果

  • 基于人群研究,纳入162,576例妊娠,暴露为Covid-19感染(包括严重程度、感染时期及流行变异株),结局为妊娠至产后42天内的严重孕产妇疾病。
  • Covid-19感染与严重孕产妇疾病风险约翻倍相关(RR 2.02,95%CI 1.76-2.31)。
  • 急性肾衰竭风险升高(RR 3.01,95%CI 1.79-5.06);栓塞、休克、脓毒症和弥散性血管内凝血(RR 1.35,95%CI 0.95-1.93)未达统计学显著;严重出血风险升高(RR 1.49,95%CI 1.09-2.04)。
  • 重度产前感染(RR 13.60,95%CI 10.72-17.26)和围产期感染(RR 20.93,95%CI 17.11-25.60)与严重孕产妇疾病强烈相关;轻度产前感染亦升高风险(RR 3.43,95%CI 2.42-4.86)。
  • 野生型、alpha和delta变异株流行期间严重孕产妇疾病风险约升高3倍,omicron流行期间约1.2倍。

证据类型、等级与局限

  • 证据类型:基于人群的研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 妊娠期Covid-19感染可能增加严重孕产妇疾病风险,包括肾脏、栓塞及出血并发症。
  • 重度Covid-19感染伴任何变异株、产前或围产期感染均可能增加严重孕产妇疾病风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: We examined the risk of severe life-threatening morbidity in pregnant patients with Covid-19 infection.

METHODS: We conducted a population-based study of 162,576 pregnancies between March 2020 and March 2022 in Quebec, Canada. The main exposure was Covid-19 infection, including the severity, period of infection (antepartum, peripartum), and circulating variant (wildtype, alpha, delta, omicron). The outcome was severe maternal morbidity during pregnancy up to 42 days postpartum. We estimated risk ratios (RR) and 95% confidence intervals (CI) for the association between Covid-19 infection and severe maternal morbidity using adjusted log-binomial regression models.

RESULTS: Covid-19 infection was associated with twice the risk of severe maternal morbidity compared with no infection (RR 2.02, 95% CI 1.76-2.31). Risks were elevated for acute renal failure (RR 3.01, 95% CI 1.79-5.06), embolism, shock, sepsis, and disseminated intravascular coagulation (RR 1.35, 95% CI 0.95-1.93), and severe hemorrhage (RR 1.49, 95% CI 1.09-2.04). Severe antepartum (RR 13.60, 95% CI 10.72-17.26) and peripartum infections (RR 20.93, 95% CI 17.11-25.60) were strongly associated with severe maternal morbidity. Mild antepartum infections also increased the risk, but to a lesser magnitude (RR 3.43, 95% CI 2.42-4.86). Risk of severe maternal morbidity was around 3 times greater during circulation of wildtype and the alpha and delta variants, but only 1.2 times greater during omicron.

CONCLUSIONS: Covid-19 infection during pregnancy increases risk of life-threatening maternal morbidity, including renal, embolic, and hemorrhagic complications. Severe Covid-19 infection with any variant in the antepartum or peripartum periods all increase the risk of severe maternal morbidity.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Auger N, Ukah UV, Wei SQ, et al. Impact of Covid-19 on risk of severe maternal morbidity. Crit Care. 2023. PMID: 37670329. doi:10.1186/s13054-023-04584-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。